Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trialMinoo Mohraz, Hamed Hosseini, Erfan Ghasemi et al.|BMJ|2023Cited by 17
Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adultsMinoo Mohraz, Hamed Hosseini, Mohammadreza Salehi et al.|BMJ Open|2022Cited by 16